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Abstract
BACKGROUND—A recent study showed that methylphenidate induces emergence from
isoflurane general anesthesia. Isoflurane and propofol are general anesthetics that may have
distinct molecular mechanisms of action. The objective of this study was to test the hypothesis that
methylphenidate actively induces emergence from propofol general anesthesia.
METHODS—Using adult rats, the effect of methylphenidate on time to emergence after a single
bolus of propofol was determined. The ability of methylphenidate to restore righting during a
continuous target controlled infusion of propofol was also tested. In a separate group of rats, a
target controlled infusion of propofol was established and spectral analysis was performed on
electroencephalogram recordings taken before and after methylphenidate administration.
RESULTS—Methylphenidate decreased median time to emergence after a single dose of
propofol from 735 seconds (95% CI: 598 to 897 seconds, n=6) to 448 seconds (95% CI: 371 to
495 seconds, n=6). The difference was statistically significant (p = 0.0051). During continuous
propofol anesthesia with a median final target plasma concentration of 4.0 μg/ml (95%CI: 3.2 to
4.6, n=6), none of the rats exhibited purposeful movements after injection of normal saline. After
methylphenidate, however, all 6 rats promptly exhibited arousal and had restoration of righting
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with a median time of 82 seconds (95% CI: 30 to 166 seconds). Spectral analysis of
electroencephalogram data demonstrated a shift in peak power from delta (<4 Hz) to theta (4–8
Hz) and beta (12–30 Hz) after administration of methylphenidate, indicating arousal in 4/4 rats.
CONCLUSIONS—Methylphenidate decreases time to emergence after a single dose of propofol,
and induces emergence during continuous propofol anesthesia in rats. Further study is warranted
to test the hypothesis that methylphenidate induces emergence from propofol general anesthesia in
humans.
INTRODUCTION
Anesthesiologists routinely reverse the actions of many drugs including opioids,
benzodiazepines, muscle relaxants, and anticoagulants. However, emergence from general
anesthesia is still treated as a passive process, dictated by the pharmacokinetics of anesthetic
drug clearance. The classical approach of developing drugs that antagonize the actions of
general anesthetics at the molecular level has not been feasible, due to the lack of clearly
defined molecular targets through which general anesthetics induce loss of consciousness.
However, at the level of neural circuits and systems, there is growing evidence to suggest
that arousal pathways play important roles in emergence from general anesthesia.1–10 We
recently reported that methylphenidate, an inhibitor of dopamine and norepinephrine
reuptake transporters, actively induces emergence from isoflurane general anesthesia in
rats.11 Methylphenidate restored the righting reflex, induced electroencephalogram changes
consistent with arousal, and increased respiratory drive. The behavioral and respiratory
effects induced by methylphenidate were inhibited by droperidol, supporting the idea that
methylphenidate induces arousal by activating a dopaminergic arousal pathway.
Propofol is a widely used intravenous general anesthetic thought to produce its effects by
enhancing the function of specific γ-aminobutyric acid type A receptors that contain β3
subunits. Transgenic mice harboring a point mutation in the β3 subunit of the γ-
aminobutyric acid type A receptor are resistant of the anesthetizing effects of propofol and
etomidate but not volatile anesthetics,12,13 suggesting that the molecular mechanisms of
action may be distinct for these two classes of general anesthetics. However, because
methylphenidate likely induces emergence from isoflurane general anesthesia by activating
monoaminergic arousal pathways rather than molecular level antagonism, we hypothesized
that methylphenidate induces emergence from propofol anesthesia.
To test this hypothesis a rodent model was used to determine the effect of methylphenidate
vs. normal saline (vehicle) on time to emergence after a bolus dose of propofol. We also
investigated whether methylphenidate restores the righting reflex during a continuous, target
controlled infusion of propofol. Finally, we performed spectral analysis on
electroencephalogram recordings taken during continuous target controlled infusions of
propofol to test whether methylphenidate induces neurophysiological evidence of arousal.
MATERIALS AND METHODS
Animal care and use
Animal studies were approved by the Subcommittee on Research Animal Care,
Massachusetts General Hospital, Boston, Massachusetts, which serves as our Institutional
Animal Care and Use Committee. Ten male Sprague-Dawley rats (Charles River
Laboratories, Wilmington, MA) weighing 375–508 grams were used for these studies. Six
rats were used for the propofol bolus experiments and the continuous infusion experiments,
in random order. At least 3 days of rest were provided between experiments. Four additional
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rats with implanted extradural electrodes were used for the electroencephalogram
experiments. Animals were kept on a standard day-night cycle (lights on at 7:00 AM, and
off at 7:00 PM), and all experiments were performed during the day.
Preparation and delivery of drugs
Isoflurane, methylphenidate hydrochloride, and propofol were obtained from Henry Schein
(Melville, NY), Sigma-Aldrich (St. Louis, MO), and APP pharmaceuticals (Shaumburg, IL)
respectively. Sterile normal saline, methylphenidate, and propofol were always administered
intravenously. Methylphenidate was weighed, dissolved in 0.5 ml of normal saline, and
sterile filtered immediately prior to administration. The IV tubing (approximate volume 0.6
ml) was always flushed with 2 ml of normal saline after a bolus dose of propofol or
methylphenidate was administered, to ensure complete delivery of drug. Investigators were
not blinded (i.e. the identity of the administered drug was always known).
For continuous propofol infusions, STANPUMP* was run on an IBM Thinkpad T43
computer interfaced with a Physio 22 syringe pump (Harvard Apparatus, Holliston, MA).
The pharmacokinetic file for propofol in rats was based on data published by Knibbe et al.14
and kindly provided by Dr. Steven L. Shafer, Columbia University, New York, NY. A
constant plasma target concentration mode was selected and the drug was delivered through
a dedicated lateral tail vein IV catheter.
Time to Emergence After Propofol Bolus
A single 24-gauge intravenous catheter was placed in a lateral tail vein during brief general
anesthesia with isoflurane (2% to 3%) in oxygen, and then the animal was allowed to fully
recover from the isoflurane general anesthetic in room air. At least 10 minutes after
returning to a baseline level of activity, a bolus dose of propofol (8mg/kg IV) was
administered. This dose was chosen because it is approximately twice the published EC50
dose for loss of righting.15 All rats lost the righting reflex within 30 seconds, and were
gently placed in the supine position on a heating pad. Forty-five seconds after administration
of propofol, methylphenidate (5 mg/kg IV) or normal saline (vehicle) was administered.
Time to emergence was defined as the time from administration of propofol until restoration
of the righting reflex (i.e. all four paws touching the floor). The same six rats were used on
different days (at least 3 days apart) for both the normal saline group and the
methylphenidate group. A crossover design was used (i.e. half of the animals received
normal saline on the first day and methylphenidate on the second day, and the other half
underwent the experiments in reverse order).
Administration of Methylphenidate During Continuous Propofol General Anesthesia
Rats were anesthetized in an induction chamber with 2% to 3% isoflurane in oxygen prior to
the placement of two 24-gauge intravenous catheters, one on each lateral tail vein. One
catheter was used as a dedicated line for the continuous target controlled infusion of
propofol, and the other was used for bolus administration of methylphenidate or normal
saline. The catheter used for bolus administration was kept open by using a second syringe
pump that continuously infused normal saline at a rate of 2 ml/hr. After initiating the
propofol infusion, isoflurane was discontinued and the rats were placed in the supine
position on a heating pad in room air. A rectal temperature probe was used to maintain core
body temperature between 36.5°C and 37.4°C.
*STANPUMP program. Available at: http://www.opentcl.org. Last accessed 4/26/2011.
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To establish the minimum target plasma concentration of propofol sufficient to maintain loss
of righting, the propofol infusion was initiated with a target plasma dose of 5.0 μg/ml. If the
rat did not exhibit any purposeful movements, the propofol concentration was lowered by
0.5 μg/ml every 10 minutes. If the rat exhibited purposeful movements, the propofol
concentration was increased until purposeful movements were no longer observed, and then
lowered by 0.5 μg/ml every 10 minutes. The final target concentration was defined as 0.5
μg/ml above the highest dose at which purposeful movements were observed, and fixed for
the remainder of the experiment. Pilot studies indicated that this protocol most reliably
provided a steady state propofol general anesthetic with continuous loss of righting.
Establishing the final dose of propofol took a minimum of 45 minutes, during which time
the rats inhaled room air and were not exposed to isoflurane. Fifteen minutes after arriving
at the final target concentration for propofol, a bolus of normal saline was administered and
the temperature probe was removed, to confirm that these mildly stimulating maneuvers
were insufficient to induce an arousal response. At the final dose of propofol, no animal
exhibited purposeful movement after bolus injection of normal saline or removal of the
temperature probe. Five minutes after the normal saline bolus, methylphenidate (5 mg/kg
IV) was administered. The experiment was terminated when the rat regained the righting
reflex or when 30 minutes had elapsed after methylphenidate administration, whichever
came first.
Electroencephalogram Electrode Placement, Recording, and Spectral Analysis
Extradural electroencephalogram electrodes were surgically implanted at least 7 days prior
to recording. General anesthesia was induced and maintained with isoflurane. A microdrill
(Patterson Dental Supply Inc., Wilmington, MA) was used to make four holes at the
following stereotactic coordinates: A0L0, A6L3, A6L-3, and A10L2 relative to the
lambda.16 An electrode with mounting screw and socket (Plastics One, Roanoke, VA) was
screwed into each hole, and the sockets were inserted in a pedestal (Plastics One). The
screws, sockets and pedestal were all permanently fixed with dental acrylic cement, and the
animal underwent a minimum recovery period of 7 days.
On the day of recording, the potential difference between electrodes A0L0 and A6L3 (right
somatosensory cortex) or between electrodes A0L0 and A6L-3 (left somatosensory cortex)
was recorded based on which signal gave less motion artifact. The signal was referenced to
A10L2 and recorded using a QP511 Quad AC Amplifier System (Grass Instruments, West
Warwick, RI) and a USB- 6009 14-bit data acquisition board (National Instruments, Austin,
TX). The sampling rate was 512 Hz, and no line filter was used. Data was filtered between
0.3 Hz and 50 Hz. A 10-minute baseline electroencephalogram was recorded during the
awake state prior to the induction of general anesthesia.
In order to decrease motion artifacts associated with righting attempts, a higher dose of
propofol was used for these studies. Using the same procedure described above in
“Administration of Methylphenidate During Continuous Propofol General Anesthesia”
(second paragraph), the final target concentration of propofol was established and
maintained at 1.0 μg/ml above the highest dose at which purposeful movements were
observed. After 15 minutes at the final dose of propofol, the electroencephalogram signal
was recorded for an additional 10 minutes, and then normal saline was injected. None of the
animals exhibited purposeful movement during or after administration of normal saline. Five
minutes later, methylphenidate (5 mg/kg IV) was administered. Although we initially
attempted to perform the electroencephalogram experiments at the same dose of propofol as
the experiments described in the previous section, the animals moved too vigorously after
the administration of methylphenidate. Therefore the higher dose of propofol was necessary
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to attenuate the methylphenidate-induced arousal response and reduce motion artifacts on
the electroencephalogram.
Spectral analysis was performed using Matlab R2010b (Mathworks, Natick, MA) and
Chronux software (Cold Spring Harbor, NY),17 as previously described.11 Briefly, mean
power spectra were compared before and after methylphenidate administration using
Kolmogorov-Smirnov tests.18 To determine the difference between two spectra, a two-
sample Kolmogorov-Smirnov test19 was performed on the spectral power as a function of
frequency computed from the 30 windows in the pre-methylphenidate and post-
methylphenidate periods. We used a Bonferroni correction to adjust the significance level
for multiple hypothesis-testing.
Statistical Analysis
Prism 4.03 (Graphpad Software, San Diego, CA) and Matlab R2010b (Mathworks, Natick,
MA) were used for statistical analysis. Statistical significance was defined as a p value less
than 0.05. The Mann-Whitney test was used to test the hypothesis that methylphenidate
decreases time to emergence after a bolus dose of propofol.
To compare the effect of methylphenidate versus normal saline on return of righting during
continuous propofol general anesthesia we use a Bayesian Monte Carlo procedure to
compute Bayesian 95% (credibility) confidence intervals for the difference in the righting
probabilities of the two groups. We also use the algorithm to compute the probability that
the righting probability in one group is greater than the righting probability in the other
group. Let pi denote the probability of righting for the animals in group i, where i = m is the
methylphenidate group and i = s is the saline group. If there are n animals in each group, let
ki be the number of animals in group i that right. Because each animal in a given group
either has return of the righting reflex or does not, the outcome of the experiment for each
animal is Bernoulli and the joint distribution or likelihood for the animals in group i is the
binomial model20
(1)
To perform a Bayesian analysis we assume that the prior density for pi is the beta probability
model20
(2)
for pi ∈ (0,1), parameters α > 0 and β > 0, and  is the standard
gamma function. It follows that the posterior density for group i is the gamma probability
density20
(3)
For our analyses we take α = β = 1 in Eq. 2 so that the prior density for both groups is the
uninformative, uniform probability density on the interval (0,1). Given the posterior
densities for the methylphenidate and the saline groups, we compute the posterior density f
(pm − ps | km, ks) by using the following Monte Carlo algorithm:
1. Draw pm from f (pm | km)
2. Draw ps from f (ps | ks)
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3. Compute pm − ps
4. Do 1 to 3 10,000 times.
The histogram of the 10,000 pm − ps values is a Monte Carlo approximation to the posterior
density f (pm − ps | km, ks). The lower and upper limits of the 95% Bayesian credibility
(confidence) interval are 250th smallest value 9,750th smallest value in the Monte Carlo
sample respectively. We compute the probability that pm − ps as ,
where ℓ is the number of times that pm > ps in the Monte Carlo sample. Unlike confidence
intervals computed using frequentist methods, the Bayesian 95% confidence intervals can be
interpreted as having probability 0.95 that the value of pm − ps lies between the lower and
upper limits of the interval based on the data in the current sample.20 We used this Monte
Carlo algorithm in our previous studies using methylphenidate to induce active emergence
from isoflurane general anesthesia.11
RESULTS
Methylphenidate Decreases Time to Emergence After a Propofol Bolus
Figure 1A summarizes the protocol for this experiment. As shown in Figure 1B, the median
time to emergence for animals that received normal saline was 735 seconds (95% CI: 598 to
897 seconds, n=6) versus 448 seconds (95% CI: 371 to 495 seconds, n=6) for animals that
received methylphenidate. The median difference in time to emergence between these two
groups was 282 seconds (95% CI: 166 to 458 seconds, Mann-Whitney test). This median
difference was statistically significant (p = 0.0051).
Methylphenidate Restores the Righting Reflex During Continuous Propofol General
Anesthesia
Figure 2A summarizes the protocol for this experiment. The final target concentration of
propofol was maintained at a dose 0.5 μg/ml above the highest dose at which purposeful
movements were observed, and fixed for the remainder of the experiment. The median final
target plasma concentration of propofol was 4.0 (95% CI: 3.2 to 4.6, n=6). The results of the
experiment are shown in Figure 2B. During continuous propofol anesthesia, none of the rats
exhibited purposeful movements after intravenous injection of normal saline or removal of
the temperature probe (n=6). However, after administration of methylphenidate (5 mg/kg
IV), all of the rats promptly exhibited signs of arousal (e.g. lifting of the head, blinking of
the eyes, twisting of the torso, kicking, clawing, and grooming) and had restoration of
righting within 4 minutes, with a median time of 82 sec (95% CI: 30 to 166 sec, n=6). The
Bayesian 95% CI for the difference in the propensities to have return of righting between
rats in the methylphenidate group and those in the normal saline group was 0.373 to 0.968.
The posterior probability was 0.9995.
Methylphenidate Induces Changes in Electroencephalogram Spectral Content that
Correlate with Increased Arousal
The electroencephalogram was recorded from four rats with pre-implanted extradural
electrodes over the somatosensory cortex. In order to minimize motion artifacts, the final
target concentration of propofol was maintained at a higher dose (1.0 μg/ml above the
highest dose at which purposeful movements were observed), and fixed for the remainder of
the experiment. Typical raw electroencephalogram traces recorded from a single rat are
shown in Figure 3. In the awake state before the administration of any drugs, animals
showed an active high-frequency, low-amplitude electroencephalogram pattern, which
changed to a low-frequency, high-amplitude pattern during the target controlled infusion of
propofol.
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Although the electroencephalogram pattern did not change after injection of normal saline or
removal of the temperature probe, administration of methylphenidate (5 mg/kg IV) induced
a shift back to an active high-frequency, low-amplitude pattern similar to that observed
during the awake state. This change persisted for more than 10 minutes despite the
continuous target controlled infusion of propofol. After the administration of
methylphenidate none of the rats had restoration of righting at this higher dose of propofol,
but all four exhibited varying behavioral signs of arousal (e.g. opening of the eyes, lifting of
the head, kicking, etc.).
To assess changes in electroencephalogram power over time, spectrograms were computed
from the continuous unfiltered electroencephalogram data recorded from each animal.
Typical results from an individual rat are shown in Figure 4. During the awake state,
electroencephalogram power was mainly in the theta frequency range (4–8 Hz). However,
the target controlled infusion of propofol caused a large increase in delta power (<4 Hz).
Although intravenous injection of normal saline produced no appreciable change in the
power spectrum, administration of methylphenidate (5 mg/kg IV) produced a prompt
reduction in delta power and increase in theta and beta power (12–30 Hz), providing
evidence for a new arousal state distinct from the baseline awake state.
Figure 5 shows spectrograms and power spectra from four different animals during
continuous target controlled infusions of propofol, with the results of the Kolmogorov-
Smirnov test computed from two-minute time windows before and after methylphenidate
administration. At a 0.05 significance level the two-sided Kolmogorov-Smirnov test with
Bonferonni correction rejects the null hypothesis at all frequencies except those marked with
white squares. Methylphenidate (5 mg/kg IV) decreased delta power and increased theta and
beta power in all 4 animals. The difference in power before and after methylphenidate was
statistically significant at most frequencies between 0–30 Hz.
DISCUSSION
In this study we found that methylphenidate induces emergence from propofol general
anesthesia in rats. Methylphenidate decreased time to emergence after a propofol bolus, and
induced emergence during a continuous target controlled infusion of propofol. The effects of
methylphenidate (5 mg/kg IV) were dependent on the dose of propofol. When the target
plasma concentration of propofol was fixed at a dose 0.5 μg/ml above the highest dose at
which purposeful movements were observed, methylphenidate restored the righting reflex.
At a higher dose of propofol, methylphenidate induced electroencephalogram changes and
varying behaviors consistent with arousal, but did not restore the righting reflex. The
electroencephalogram pattern induced by methylphenidate during propofol general
anesthesia was not identical to the pattern observed during the baseline awake state in the
absence of drugs, suggesting that the two arousal states are distinct.
Although isoflurane general anesthesia was used for tail vein IV placement, the procedure
typically took less than 5 minutes, and isoflurane was promptly discontinued after the IV
was secured. For the bolus experiments, propofol was delivered at least 10 minutes after the
animal recovered a baseline level of normal activity. For the continuous infusion
experiments, establishing the final dose of propofol took a minimum of 45 minutes, during
which time the rats inhaled room air and were not exposed to isoflurane. In both cases,
residual isoflurane levels were likely minimal at the time methylphenidate was administered.
There has been a growing interest in the role of ascending arousal pathways in emergence
from general anesthesia.2,7 The injection of nicotine in the central medial thalamus induces
emergence from sevoflurane anesthesia in rats,4 and physostigmine, a centrally-acting
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cholinesterase inhibitor, restored consciousness in human volunteers during sevoflurane
anesthesia10 as well as propofol anesthesia.5 These studies demonstrate that emergence from
general anesthesia can be achieved by activating central cholinergic neurotransmission. It
was recently reported that injection of the arousal-promoting neurotransmitters histamine or
norepinephrine into the nucleus basalis magnocellularis induces behavioral and
neurophysiological evidence of arousal during general anesthesia,21,22 providing evidence
that monoaminergic arousal pathways are also important for emergence from general
anesthesia.
We recently reported that methylphenidate induces emergence from isoflurane general
anesthesia, an effect that is inhibited by droperidol.11 Methylphenidate acts by blocking
dopamine and norepinephrine reuptake transporters,23 and it likely antagonizes the effects of
isoflurane and propofol by activating a combination of dopaminergic, noradrenergic, and/or
histaminergic arousal pathways.11 Transgenic mice harboring a point mutation in the β3
subunit of the γ-aminobutyric acid type A receptor are highly resistant to the anesthetizing
effects of propofol but not volatile anesthetics,12,13 suggesting that propofol and isoflurane
may produce general anesthesia by distinct molecular mechanisms. While the present study
does not prove the mechanism of action of methylphenidate, the finding that
methylphenidate induces emergence from both isoflurane and propofol general anesthesia
further supports the hypothesis that methylphenidate acts by activating monoaminergic
arousal pathways at the circuit level, rather than antagonizing general anesthetics at the
molecular level.
In our previous study we used plethysmography to show that methylphenidate also increases
respiratory drive in rats anesthetized with isoflurane.11 We concluded that the increase in
minute ventilation induced by methylphenidate likely accelerated isoflurane elimination and
contributed to the decrease in time to emergence. In this study we did not perform
plethysmography experiments during propofol general anesthesia, because unlike inhaled
anesthetics, the elimination of propofol does not involve the pulmonary system. However,
there is considerable evidence that activating dopaminergic neurotransmission increases
respiratory drive,24–26 so it is reasonable to predict that methylphenidate would also
stimulate breathing during propofol general anesthesia. It is noteworthy that the animals in
the present study inhaled room air (unlike the animals in our previous study that inhaled
pure oxygen as the carrier gas for isoflurane), demonstrating that hyperoxia is not necessary
for methylphenidate to induce emergence from general anesthesia.
To our knowledge, this is the first study to report the use of a STANPUMP-based target
controlled infusion to maintain propofol general anesthesia in rodents. The rat
pharmacokinetic profile was based on allometric extrapolations comparing adults, children
and rats.14 Our results suggest that these kinetic parameters can be used to maintain a
reliable steady-state general anesthetic with propofol. However, one weakness of this study
is that we did not assay the propofol concentrations in blood over time to confirm that the
target controlled infusion was providing a stable plasma concentration. Because we used
long equilibration times and a careful titration protocol to arrive at the final dose of
propofol, however, it is unlikely that large changes in the effect site concentration of
propofol were occurring at the time of methylphenidate administration.
It has been reported that patients taking methylphenidate have an increased requirement for
propofol,27,28 which agrees with the findings of this study. Further study is warranted to test
the hypothesis that methylphenidate induces emergence from propofol general anesthesia in
humans. Methylphenidate may be useful to restore consciousness in patients oversedated
with propofol, and to induce emergence from propofol general anesthesia after prolonged
infusions. Methylphenidate has a well-established safety profile in both children and adults
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for the treatment of Attention Deficit Hyperactivity Disorder.23 The results of the present
study suggest that methylphenidate may be a clinically useful to induce emergence from
propofol general anesthesia. The availability of such a drug may lead to improved patient
safety and operating room efficiency.
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What we already know about this topic
• The psychostimulant methylphenidate was recently found to induce emergence
from isoflurane anesthesia in rats, but its effects on anesthesia produced by other
agents is unclear
What this article tells us that is new
• Methyphenidate enhanced emergence from intravenous propofol in rats, which
was accompanied by a shift in the electrocephalogram to higher frequencies
• Further studies are required to determine whether methylphenidate might
provide a useful agent to facilitate emergence from general anesthesia in
humans
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Fig. 1.
Methylphenidate decreases time to emergence from propofol anesthesia. (A) Rats received a
bolus of propofol (8 mg/kg IV), and 45 seconds later, received methylphenidate (5 mg/kg
IV) or normal saline (vehicle). Time to emergence was defined as the time from
administration of propofol to return of righting (i.e. all four paws touching the floor). (B)
Scatter plot of time to emergence for rats that received normal saline vs. methylphenidate (5
mg/kg IV). The lines represent the medians. ** P<0.01.
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Fig. 2.
Methylphenidate induces emergence during a continuous target controlled infusion of
propofol. (A) The final target plasma concentration of propofol was established at 0.5 μg/ml
above the highest dose at which purposeful movements were observed, and maintained for
15 minutes before normal saline (vehicle) was injected. Five minutes later, methylphenidate
(5 mg/kg IV) was administered. The propofol infusion was continued at the same dose. (B)
None of the rats exhibited an arousal response during the 5 minutes after normal saline
administration (n=6). However, methylphenidate induced a profound arousal response and
restored the righting reflex within 4 minutes in all rats (n=6), despite continuous propofol
general anesthesia. ***posterior probability > 0.95.
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Fig. 3.
Methylphenidate induces electroencephalogram changes during a continuous target
controlled infusion of propofol. Thirty-second epochs of electroencephalogram recordings
from a single rat show the change from an active, theta-dominant pattern during the awake
state to a delta-dominant pattern during the continuous target controlled infusion of
propofol. The latter pattern was unchanged after the administration of normal saline, but
after administration of methylphenidate (MPH, 5 mg/kg IV) there was a shift in the
electroencephalogram back to an active theta-dominant pattern similar to that observed
during the awake state. This pattern persisted for more than 10 minutes.
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Fig. 4.
Spectral analysis of electroencephalogram data reveals a shift in power induced by
methylphenidate during a continuous target controlled infusion of propofol. Warm colors
(e.g. red) represent higher power at a given frequency, while cool colors (e.g. blue) represent
lower power. (A) A representative spectrogram computed from a rat in the awake state
shows predominance of theta power (4–8 Hz). (B) A representative spectrogram computed
from a rat during propofol general anesthesia shows predominance of delta power (<4 Hz)
before and after administration of normal saline. However, administration of
methylphenidate (MPH, 5 mg/kg IV) promptly reduced delta power, and increased theta (4–
8 Hz) and beta power (12–30 Hz), providing evidence for a new arousal state distinct from
the baseline awake state.
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Fig. 5.
Electroencephalogram power spectra and spectrograms computed for each of 4 animals
reveal a consistent shift in peak power from delta to theta and beta after administration of
methylphenidate during continuous propofol general anesthesia. (A) A schematic showing
the two-minute windows used to compute power spectra before methylphenidate
administration (blue, “PRE”), and after methylphenidate administration (red, “POST”). (B)
Spectrograms computed from 4 different animals that received methylphenidate at the time
point indicated by the vertical dashed line. (C) Power spectra computed from the same
animals with results of the Kolmogorov-Smirnov test for the two-minute periods before
(blue) and after (red) methylphenidate administration. At a 0.05 significance level (with
Bonferonni correction) the Kolmogorov-Smirnov test rejects the null hypothesis at all
frequencies except those marked with white squares. Statistically significant changes
occurred at most frequencies between 0–30 Hz. (D) Power spectra computed from the same
animals with results of the Kolmogorov-Smirnov test, comparing a two-minute period from
the baseline awake state in the absence of any drugs (green) to the two-minute period after
methylphenidate administration during continuous propofol general anesthesia (red).
Statistically significant changes occurred at most frequencies between 0–30 Hz.
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